| Ytd | 13.67% | |
| 1y | 27.03% |
| Open | 65.72 | Prev Close | 65.89 | Low | 65.22 | High | 67.16 | Mkt Cap | 3.05B |
| Vol | 379.26K | Avg Vol | 1.03M | EPS | -14.81 | P/E | N/A | Forward P/E | 15.46 |
| Beta | 0.43 | Short Ratio | 5.20 | Inst. Own | 112.99% | Dividend | 1.67 | Div Yield | 2.53 |
| Ex Div Date | 06-01 | Earning | 07-28 | 50-d Avg | 58.78 | 200-d Avg | 56.28 | 1yr Est | 67.91 |
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults w
https://www.bloomberg.com/news/articles/2026-06-18/chemicals-maker-ashland-pushed-to-sell-by-activis
Ancora unveils new Ashland campaign at Wolfe Research conferencePushes for company to start strategi